We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Urine Circulating Anodic Antigen Test Diagnoses Schistosomiasis

By LabMedica International staff writers
Posted on 27 May 2015
Print article
Image: Egg of Schistosoma haematobium in a wet mount of urine concentrates, showing the characteristic terminal spine (Photo courtesy of US Centers for Disease Control and Prevention).
Image: Egg of Schistosoma haematobium in a wet mount of urine concentrates, showing the characteristic terminal spine (Photo courtesy of US Centers for Disease Control and Prevention).
An accurate diagnosis is essential and should be adapted to the specific stage of a schistosomiasis control program and parasitological methods to detect Schistosoma eggs in stool are widely used.

These conventional parasitological methods are insensitive for the detection of light-intensity infections and techniques with high sensitivity and specificity are required for an accurate diagnosis in low-transmission settings and verification of elimination.

An international team of scientists led by those at the Swiss Tropical and Public Health Institute (Basel, Switzerland) collected a total of 1,740 urine samples in 2013 from children on Pemba Island (Tanzania). The children attended schools where the S. haematobium prevalence was less than 2%, 2% to 5%, and 5% to 10%, based on a single urine filtration. On the day of collection, all samples were tested for microhematuria with reagent strips and for the presence of S. haematobium eggs with microscopy.

The team determined the accuracy of a urine-based up-converting phosphor-lateral flow circulating anodic antigen (UCP-LF CAA) assay on 1,200 samples eight months later, while urine filtration slides were subjected to quality control (QCUF). In the absence of a true “gold” standard, the diagnostic performance was calculated using latent class analyses (LCA). The UCP-LF CAA designated UCAA2000 is currently considered to show the best trade-off between a high sensitivity and convenient field applicability.

The “empirical” S. haematobium prevalence revealed by UCP-LF CAA, QCUF, and reagent strips was 14%, 5%, and 4%, respectively. LCA revealed a sensitivity of the UCP-LF CAA, QCUF, and reagent strips of 97%, 86%, and 67% respectively. Test specificities were consistently above 90%. Since QCUF revealed more S. haematobium-infected individuals than the initial urine filtration microscopy, only QCUF results were considered for the calculation of sensitivity and specificity. There was a significant relationship between circulating anodic antigen CAA pg/mL levels and S. haematobium egg counts, between CAA pg/mL levels and microhematuria grading, and between egg counts and microhematuria grading.

The authors concluded that the UCAA2000 as a suitable tool for large-scale monitoring of urogenital schistosomiasis in control programs in low-endemicity settings targeting elimination and for surveillance in areas that achieved elimination. For surveillance at a smaller scale, including testing of suspected cases in remote public health care centers without laboratory equipment, a simple-to-use but still highly sensitive point-of-care-CAA rapid test is highly desirable. The study was published on May 14, 2015, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Swiss Tropical and Public Health Institute 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.